Skip to main content

Proactive news headlines including Pfizer, Silverton Metals, Marble, Aurelius Minerals, Doré Copper Mining, Mindset Pharma and RespireRx Pharmaceuticals

Written by Customer Service on . Posted in Mergers And Acquisitions.

New York , Jan. 25, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

  • Pfizer and BioNTech set to begin trials of Omicron specific vaccine click here
  • Haywood Capital Markets targets C$1.40 a share for Red Pine Exploration as company bids to extend Surluga resource click here
  • Silverton Metals completes geophysical 3D modeling and starts seismic survey at its Pluton silver-zinc-lead project in Mexico click here
  • Pathfinder Ventures pledges to support electric RVs at its Pathfinder Camp Resorts click here
  • Contakt World releases latest version of HealthCheck as it looks to broadens its portfolio click here
  • Scottie Resources reports high-grade gold intercepts at the Blueberry Zone in British Columbia’s Golden Triangle click here
  • HighGold Mining discovers new gold-bearing structure at Johnson Tract defining a prospective target corridor in Alaska click here
  • Amvest Capital and Welsbach Holdings form new energy material fund click here
  • Canadian Securities Exchange reports record 2021 performance click here
  • Marble announces new rent reporting service for its MyMarble platform, powered by FrontLobby click here
  • OTC Markets Group announces fourth quarter 2021 performance and quarterly index rebalancing click here
  • Melkior Resources lays out plans to follow up on multiple targets in 2022 at Val d’Or property click here
  • Altaley Mining posts preliminary 4Q revenue of C$19.9M from Campo Morado in Mexico click here
  • Snowline Gold makes second ‘significant’ gold discovery in the Yukon at Valley target click here
  • Doré Copper Mining announces 2022 drilling program at flagship Corner Bay and Devlin projects click here
  • Nextech AR joins Khronos Group as a contributor member for creating advanced technology click here
  • DGTL reports new $200,000 campaign for Nasdaq-listed esports gaming client click here
  • The Valens Company launches two new cannabis brands in the value and premium markets click here
  • ImagineAR signs licensing agreement with Jet Media Network to provide immersive augmented reality for celebrity mobile apps click here
  • RespireRx Pharmaceuticals notes publication of paper on GABAkine KRM-II-81, which it is advancing for epilepsy and pain click here
  • Tribe Property Technologies announces partnership with NextLevel Drycleaners click here
  • Mindset Pharma enters manufacturing deal with leading CDMO for next-generation psilocybin drug candidate, MSP-1014 click here
  • Fobi AI integrates with US payments giant Square offering real-time data analytics to retailers around the globe click here
  • ESE signs agreement with Skinwallet to enter metaverse with gaming and esports projects click here
  • Aurelius Minerals says it is encouraged by latest drill results from Aureus East ahead of updated resource this quarter click here
  • HC Wainwright reiterates ‘Buy’ rating on Predictive Oncology and $5 price target click here

About Proactive

Proactive is a unique tech-enabled platform providing companies globally with a comprehensive investor engagement solution across their business lifecycle.

With six offices on three continents, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives to engage intelligently with investors.

In 2020, Proactive featured in 809 million search results, our content was viewed over 165 million times and our readers spent over 10 million hours on our websites. Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.

For more information on how Proactive can help you make a difference, email us at action@proactiveinvestors.com

 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.